Aussara Panya

Dr. Aussara Panya

Department of Biology, Faculty of Science, Chiang Mai University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
KNKrongkaew Navakul
Krongkaew Navakul
CWChompunuch Warakulwit
Chompunuch Warakulwit
PYPa-Thai Yenchitsomanus
Pa-Thai Yenchitsomanus
APAussara Panya
Aussara Panya
PLPeter Lieberzeit
Peter Lieberzeit
CSChak Sangma
Chak Sangma

21 February 2018 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
CTChutamas Thepmalee
Chutamas Thepmalee
APAussara Panya
Aussara Panya
MJMutita Junking
Mutita Junking
TCThaweesak Chieochansin
Thaweesak Chieochansin
PYPa-thai Yenchitsomanus
Pa-thai Yenchitsomanus
Tumor escapes host immune responses by producing immunosuppressive cytokines, such as IL-10 and TGF-β, secreted into the tumor microenvironment. These cytokines play important roles in the suppression of dendritic cell (DC) function, leading to decreased immune responses of the effector CD4+ and CD8+ T cells. To improve DC functions and enhance cytolytic activity of activated effector T-cells, we suppressed the effect of these cytokines on DCs by using specific neutralizing antibodies that inhibit IL-10 and TGF-β receptors. Monocyte-derived DCs generated in vitro showed up-regulation of MHC (HLA-DR) and co-stimulatory molecules (CD40 and CD86). The IL-10 and TGF-β receptors were expressed and localized on cell membrane of DCs, as shown by Western blot analysis and immunofluorescence staining, whereas the IL-10 and TGF-β ligands were detected in the culture supernatants of DCs and cholangiocarcinoma (CCA) cell line, respectively. Inhibition of the IL-10 and TGF-β receptors on DCs by specific neutralizing antibodies significantly increased level of IFN-γ and enhanced cytolytic activity of the DC-activated effector T-cells against CCA cell line. These results indicate that the IL-10 and TGF-β receptors are the targets for inhibition to increase DC functions and enhance cytolytic activity of the DC-activated effector T-cells against CCA cells. Thus, inhibition of the IL-10 and TGF-β receptors on DCs is crucial in the preparation of DC-activated effector T cells for adoptive T-cell therapy.

21 February 2022 in Pharmaceutical Biology
Verified
Journal Article
Open access
PLPongrapee Laorodphun
Pongrapee Laorodphun
RCRada Cherngwelling
Rada Cherngwelling
APAussara Panya
Aussara Panya
PAPhatchawan Arjinajarn
Phatchawan Arjinajarn
Gentamicin (GM) is an aminoglycoside antibiotic which is commonly used against Gram-negative bacterial infection; however, serious complications including nephrotoxicity could limit its clinical us...

23 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
APAussara Panya
Aussara Panya
PSPucharee Songprakhon
Pucharee Songprakhon
SPSuthida Panwong
Suthida Panwong
KJKanyaluck Jantakee
Kanyaluck Jantakee
TKThida Kaewkod
Thida Kaewkod
PYPa-thai Yenchitsomanus
Pa-thai Yenchitsomanus
Dengue virus (DENV) infection causes mild to severe illness in humans that can lead to fatality in severe cases. Currently, no specific drug is available for the treatment of DENV infection. Thus, the development of an anti-DENV drug is urgently required. Cordycepin (3′-deoxyadenosine), which is a major bioactive compound in Cordyceps (ascomycete) fungus that has been used for centuries in Chinese traditional medicine, was reported to exhibit antiviral activity. However, the anti-DENV activity of cordycepin is unknown. We hypothesized that cordycepin exerts anti-DENV activity and that, as an adenosine derivative, it inhibits DENV replication. To test this hypothesis, we investigated the anti-DENV activity of cordycepin in DENV-infected Vero cells. Cordycepin treatment significantly decreased DENV protein at a half-maximal effective concentration (EC50) of 26.94 μM. Moreover, DENV RNA was dramatically decreased in cordycepin-treated Vero cells, indicating its effectiveness in inhibiting viral RNA replication. Via in silico molecular docking, the binding of cordycepin to DENV non-structural protein 5 (NS5), which is an important enzyme for RNA synthesis, at both the methyltransferase (MTase) and RNA-dependent RNA polymerase (RdRp) domains, was predicted. The results of this study demonstrate that cordycepin is able to inhibit DENV replication, which portends its potential as an anti-dengue therapy.

1 December 2015 in Antiviral Research
Verified
Journal Article
Closed access
TRThidarath Rattanaburee
Thidarath Rattanaburee
MJMutita Junking
Mutita Junking
APAussara Panya
Aussara Panya
NSNunghathai Sawasdee
Nunghathai Sawasdee
PSPucharee Songprakhon
Pucharee Songprakhon
PYPa-thai Yenchitsomanus
Pa-thai Yenchitsomanus

12 May 2014 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
APAussara Panya
Aussara Panya
KBKunan Bangphoomi
Kunan Bangphoomi
KCKiattawee Choowongkomon
Kiattawee Choowongkomon
PYPa-thai Yenchitsomanus
Pa-thai Yenchitsomanus